Immutep Limited Adr (IMMP)

Jan 31, 2025

Immutep Quarterly Activities Report Q2 FY25 - GlobeNewswire Inc.

Jan 31, 2025

Jan 14, 2025

Immutep Limited (NASDAQ:IMMP) Shares Sold by Jane Street Group LLC - Defense World

Jan 14, 2025

Dec 18, 2024

Verition Fund Management LLC Has $57,000 Stock Position in Immutep Limited (NASDAQ:IMMP) - Defense World

Dec 18, 2024

Dec 17, 2024

Immutep Announces Initial Safety Data from First-in-Human Phase I Trial Evaluating IMP761 - The Manila Times

Dec 17, 2024

Dec 12, 2024

Immutep shares new cancer study results - Investing.com

Dec 12, 2024

Oct 29, 2024

Immutep Quarterly Activities Report Q1 FY25 - Yahoo Finance

Oct 29, 2024

Oct 17, 2024

Immutep Announces First-in-Human Phase I Study of IMP761 Progresses to Dose Escalation Portion of Trial - The Manila Times

Oct 17, 2024

Sep 17, 2024

Immutep Limited ADR (IMMP) Stock: Navigating a Year of Stock Volatility - The InvestChronicle

Sep 17, 2024

Sep 17, 2024

Metric Deep Dive: Understanding Immutep Limited ADR (IMMP) Through its Ratios - The Dwinnex

Sep 17, 2024

Sep 17, 2024

Immutep reports positive results in cancer study - Investing.com

Sep 17, 2024

Sep 16, 2024

Dow Jumps Over 200 Points; NY Empire State Manufacturing Index Increases In September - Benzinga

Sep 16, 2024

Sep 07, 2024

Research Analysts Issue Forecasts for Immutep Limited’s FY2025 Earnings (NASDAQ:IMMP) - Defense World

Sep 07, 2024

Sep 02, 2024

Immutep Limited ADR (IMMP) Stock: Navigating a Year of Volatility - The InvestChronicle

Sep 02, 2024

Aug 20, 2024

Short Interest in Immutep Limited (NASDAQ:IMMP) Declines By 10.1% - Defense World

Aug 20, 2024

Aug 14, 2024

Immutep Announces First Participant Dosed in Phase I Study of IMP761, a First in Class Agonist LAG-3 Antibody - GlobeNewswire

Aug 14, 2024

Aug 01, 2024

Immutep reports steady progress in Q4 FY24 - Investing.com

Aug 01, 2024

Aug 01, 2024

Immutep reports steady progress in Q4 FY24 By Investing.com - Investing.com Australia

Aug 01, 2024

Jul 22, 2024

Immutep Announces Successful Meeting with FDA on Phase III Design in Non-Small Cell Lung Cancer - GlobeNewswire

Jul 22, 2024

Jul 17, 2024

Immutep Receives Regulatory Clearance for Phase I Study of - GlobeNewswire

Jul 17, 2024

Jun 27, 2024

Baird cuts Immutep stock target on phase 2b trial results, retains Outperform - Investing.com

Jun 27, 2024

May 24, 2024

Stocks of the Hour: Adherium, Nanoveu, Nimy Resources - ShareCafe

May 24, 2024

Apr 18, 2024

Immutep Appoints Leading Research Institute to Conduct First-in-Human Phase I Study of IMP761 - GlobeNewswire

Apr 18, 2024

Feb 05, 2024

10 Best Australian Stocks To Buy - Yahoo Finance

Feb 05, 2024

Dec 16, 2023

Immutep LimitedADR (IMMP) Price Target Increased by 7.83% to 2.80 - MSN

Dec 16, 2023

Mar 30, 2023

Immutep Announces Expansion of Triple Combination Therapy in 1st Line Non-Small Cell Lung Cancer - GlobeNewswire

Mar 30, 2023

Dec 06, 2022

Immutep Announces GMP Manufacturing Process Developed for - GlobeNewswire

Dec 06, 2022

Nov 03, 2022

Check Up: These 4 ASX healthcare stocks come with Strong Buy recommendations - Stockhead

Nov 03, 2022

Apr 08, 2021

FDA Grants Fast Track Designation to 1L Eftilagimod Alpha for Recurrent or Metastatic HNSCC - Targeted Oncology

Apr 08, 2021

Dec 30, 2020

Best Penny Stocks To Buy For 2021? 5 Biotech Stocks To Watch - Penny Stocks

Dec 30, 2020

Jul 15, 2020

The Daily Biotech Pulse: Moderna To Kickstart Phase 3 Study On July 27, Immutep Awarded Antibody Patent - Yahoo Finance

Jul 15, 2020

Jun 01, 2018

Benzinga's Daily Biotech Pulse: Organovo Falls On Earnings; Celgene Gets New CFO - Yahoo Finance

Jun 01, 2018

Dec 05, 2017

Immutep (IMMP) Stock Price, News & Analysis - MarketBeat

Dec 05, 2017